Guard Therapeutics International AB (publ) (GUARD.ST)

SEK 18.8

(2.73%)

Gross Profit Summary of Guard Therapeutics International AB (publ)

  • Guard Therapeutics International AB (publ)'s latest annual gross profit in 2023 was -15 Thousand SEK , down 0.0% from previous year.
  • Guard Therapeutics International AB (publ)'s latest quarterly gross profit in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • Guard Therapeutics International AB (publ) reported a annual gross profit of -15 Thousand SEK in annual gross profit 2022, down 0.0% from previous year.
  • Guard Therapeutics International AB (publ) reported a annual gross profit of -15 Thousand SEK in annual gross profit 2021, up 90.68% from previous year.
  • Guard Therapeutics International AB (publ) reported a quarterly gross profit of - SEK for 2024 Q2, down 0.0% from previous quarter.
  • Guard Therapeutics International AB (publ) reported a quarterly gross profit of - SEK for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Guard Therapeutics International AB (publ) (2023 - 2011)

Historical Annual Gross Profit of Guard Therapeutics International AB (publ) (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 -15 Thousand SEK 0.0%
2022 -15 Thousand SEK 0.0%
2021 -15 Thousand SEK 90.68%
2020 -161 Thousand SEK 44.48%
2019 -290 Thousand SEK 98.71%
2018 -22.51 Million SEK -842.22%
2017 -2.39 Million SEK -20.16%
2016 -1.98 Million SEK -136.5%
2015 -841 Thousand SEK -107.62%
2014 11.03 Million SEK 34.29%
2013 8.21 Million SEK 14.11%
2012 7.2 Million SEK 151.27%
2011 2.86 Million SEK 0.0%

Peer Gross Profit Comparison of Guard Therapeutics International AB (publ)

Name Gross Profit Gross Profit Difference
Alligator Bioscience AB (publ) -160.68 Million SEK 99.991%
Ziccum AB (publ) -23.28 Million SEK 99.936%
Modus Therapeutics Holding AB (publ) - SEK Infinity%
BioArctic AB (publ) 346.31 Million SEK 100.004%
Sprint Bioscience AB (publ) 41.78 Million SEK 100.036%
Mendus AB (publ) 28.48 Million SEK 100.053%
Genovis AB (publ.) 54 Million SEK 100.028%
Intervacc AB (publ) -13.79 Million SEK 99.891%
QuiaPEG Pharmaceuticals Holding AB (publ) 2.17 Million SEK 100.691%
Active Biotech AB (publ) -1.67 Million SEK 99.104%
Magle Chemoswed Holding AB (publ) 9.96 Million SEK 100.151%
Bio-Works Technologies AB (publ) 26.82 Million SEK 100.056%
Aptahem AB (publ) 2.63 Million SEK 100.57%
Vicore Pharma Holding AB (publ) -3.42 Million SEK 99.562%
Kancera AB (publ) -1.96 Million SEK 99.237%
Infant Bacterial Therapeutics AB (publ) 77 Thousand SEK 119.481%
Fluicell AB (publ) 1.73 Million SEK 100.863%
Saniona AB (publ) 11.78 Million SEK 100.127%
Lipigon Pharmaceuticals AB (publ) -5.11 Million SEK 99.707%
Biovica International AB (publ) 6.87 Million SEK 100.218%
Spago Nanomedical AB (publ) -23.28 Million SEK 99.936%
AcouSort AB (publ) 8.38 Million SEK 100.179%
Xintela AB (publ) 78 Thousand SEK 119.231%
Abliva AB (publ) -35.66 Million SEK 99.958%
Egetis Therapeutics AB (publ) -146.9 Million SEK 99.99%
Karolinska Development AB (publ) 2.8 Million SEK 100.534%
OncoZenge AB (publ) 3000.00 SEK 600.0%
Amniotics AB (publ) -1.93 Million SEK 99.223%
2cureX AB (publ) -37.48 Million SEK 99.96%
CombiGene AB (publ) -21.29 Million SEK 99.93%
Asarina Pharma AB (publ) -423 Thousand SEK 96.454%
Calliditas Therapeutics AB (publ) 1.12 Billion SEK 100.001%
Camurus AB (publ) 1.58 Billion SEK 100.001%
Corline Biomedical AB 28.38 Million SEK 100.053%
IRLAB Therapeutics AB (publ) -122.73 Million SEK 99.988%
Isofol Medical AB (publ) -34.41 Million SEK 99.956%
I-Tech AB 27.56 Million SEK 100.054%
Hansa Biopharma AB (publ) 70.95 Million SEK 100.021%
Cyxone AB (publ) 2.61 Million SEK 100.574%
ExpreS2ion Biotech Holding AB (publ) 3.4 Million SEK 100.441%
Biosergen AB -456 Thousand SEK 96.711%
Cantargia AB (publ) -3.45 Million SEK 99.565%
NextCell Pharma AB -43.74 Million SEK 99.966%
Xspray Pharma AB (publ) -9.19 Million SEK 99.837%
Elicera Therapeutics AB (publ) 11.21 Million SEK 100.134%
Nanologica AB (publ) -76 Thousand SEK 80.263%
SynAct Pharma AB -778 Thousand SEK 98.072%
Annexin Pharmaceuticals AB (publ) -193 Thousand SEK 92.228%
Stayble Therapeutics AB (publ) - SEK Infinity%
LIDDS AB (publ) -12.92 Million SEK 99.884%
Lipum AB (publ) 53 Thousand SEK 128.302%
BioInvent International AB (publ) 71.46 Million SEK 100.021%
Alzinova AB (publ) 19.87 Million SEK 100.075%
Oncopeptides AB (publ) 36.29 Million SEK 100.041%
Pila Pharma AB (publ) 1.46 Million SEK 101.025%
Scandinavian ChemoTech AB (publ) 1.65 Million SEK 100.905%
Simris Alg AB (publ) 2 Million SEK 100.747%
Diamyd Medical AB (publ) -3.58 Million SEK 99.581%
Xbrane Biopharma AB (publ) 35.38 Million SEK 100.042%
Ascelia Pharma AB (publ) -1.04 Million SEK 98.57%
Diagonal Bio AB (publ) 3.13 Million SEK 100.479%